Sarthak Metals Limited — PPTs, 11-02-2026: Investor Presentation

Here's a concise summary of the investor presentation:

**Business Performance:** Sarthak Metals' Q3 FY26 revenue rose 8% YoY to 47.73 Cr, with PAT up 6% to 1.30 Cr. Cored wire volumes grew 1% YoY, but aluminum flipping coil volumes dipped 37% YoY, with operations temporarily paused. The welding division saw strong traction, with volumes surging 182% YoY to 409 tonnes.

**Growth Drivers or Strategy:** Sarthak is diversifying into welding and biotechnology. Welding aims for 25 Cr annual sales, driven by RDSO approval and import substitution. Biotech targets the ethanol sector, developing solutions for fermentation efficiency. Sustainability efforts include solar power, cutting electricity costs by 50%, and using recycled aluminum.

**Recent Developments:** Key recent developments include RDSO approval for the welding division in April 2025 and the operational launch of its biotech pilot facility in May 2025, engaging with ethanol distilleries.

**Key Financial Metrics:** Q3 FY26 EPS stood at 0.95, up 3% YoY. EBITDA was 2.10 Cr (4.41% margin). Biotech R&D investment totaled 0.50 Cr.

**Management Commentary / Outlook:** Management is optimistic on steel's long-term outlook despite immediate headwinds. The focus is on quality growth in cored wires and expanding new engines in welding and biotech to build a diversified, resilient company.